Finance

Beta
Lists
5GV:FRA
Genovis AB
€1,81
0,00%
(0,00) 1D
1 Jun., 08:17:51 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 5GV...
Open
€1,81
High
€1,81
Low
€1,81
Mkt. cap
1,29 mjd
Avg. vol.
0,00
Volume
0,00
52-wk high
€2,58
52-wk low
€1,41
No. of employees
36
Open
€1,81
High
€1,81
Low
€1,81
Mkt. cap
1,29 mjd
Avg. vol.
0,00
Volume
0,00
52-wk high
€2,58
52-wk low
€1,41
No. of employees
36
News stories
From sources across the web
About Genovis AB
CEOFredrik Olsson
Employees36
Founded1999
Headquarters-
SectorHealth care
Websitegenovis.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
29,05 m
27,74 m
40,54 m
33,77 m
Cost of goods sold
2,85 m
2,88 m
4,45 m
4,10 m
Cost of revenue
2,85 m
2,88 m
4,45 m
4,10 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,99 m
16,60 m
23,10 m
20,60 m
Operating expense
21,57 m
20,11 m
25,35 m
24,34 m
Total operating expenses
24,42 m
22,99 m
29,80 m
28,44 m
Operating income
4,63 m
4,75 m
10,74 m
5,33 m
Other non operating income
-
-
-
-
EBT including unusual items
3,74 m
9,31 m
7,69 m
5,48 m
EBT excluding unusual items
3,74 m
10,60 m
9,08 m
5,48 m
Income tax expense
-1,38 m
1,28 m
793,00 k
1,22 m
Effective tax rate
-36,85%
13,78%
10,31%
22,26%
Other operating expenses
-
-
-1,43 m
-
Net income
5,12 m
8,03 m
6,90 m
4,26 m
Net profit margin
17,62%
28,93%
17,02%
12,61%
Earnings per share
0,08
0,12
0,10
0,06
Interest and investment income
-
-
2,76 m
-
Interest expense
-172,00 k
-358,00 k
-3,13 m
-301,00 k
Net interest expenses
-172,00 k
-358,00 k
-369,00 k
-301,00 k
Depreciation and amortization charges
2,58 m
3,50 m
3,68 m
3,73 m
EBITDA
7,21 m
8,25 m
14,41 m
9,06 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer